Nitroxide Antioxidant SIRT2 Gene Expression Modulation
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
There is a need to effectively increase the expression levels of SIRT2 genes in human subjects, particularly those over 35, to address age-related or disease-related decreased expression levels, which are associated with various diseases and conditions such as cancer, autoimmune diseases, and aging-related disorders.
Innovation Solution
Administering an effective amount of a nitroxide antioxidant, such as 4-hydroxy-2,2,6,6-tetramethylpiperidine-1-oxyl, to human subjects identified with decreased SIRT2 expression levels, thereby increasing the expression level of SIRT2 in tissues like skin, adipose, blood, and neuronal tissues.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If gene therapy methods are used to increase SIRT2 expression levels, then the expression level of SIRT2 is improved, but the device complexity and treatment difficulty increase
Solution Approach 1:
The patent uses nitroxide antioxidants as intermediary substances that mediate between the administered compound and the SIRT2 gene expression. These antioxidants act as signaling molecules that naturally trigger increased SIRT2 expression without requiring complex gene delivery systems, thus resolving the contradiction between achieving reliable gene expression and avoiding treatment complexity
Solution Approach 2:
The patent enables the body's own cells to self-regulate SIRT2 expression in response to nitroxide antioxidant administration. The cellular machinery naturally responds to the antioxidant signal by upregulating SIRT2 production, eliminating the need for external complex intervention systems and simplifying the overall treatment approach
2Device complexity
If natural control of gene expression is allowed, then the system simplicity is maintained, but the gene expression level becomes insufficient in disease states
Solution Approach 1:
The patent changes the chemical parameter of the cellular environment by introducing nitroxide antioxidants, which alter the redox state and signaling pathways. This parameter change triggers a natural cellular response that increases SIRT2 expression, thereby maintaining system simplicity while achieving the desired improvement in gene expression levels through biochemical modulation
Data Source
AI summary
Some embodiments disclosed herein include a method for increasing an expression level of a gene. The methods include administering an effective amount of a nitroxide antioxidant to a human subject having a decreased expression level of SIRT2, whereby expression level of the gene is increased.